Frontlight ResearchEarly access
Trial site
University of Tennessee
- 8running trials
- 7closed trials
The trials here
What the 15 trials at this site are about, from their registry records.
- Conditions
- Childhood cancers2 trials
- Head and neck cancer2 trials
- Hodgkin lymphoma2 trials
- Acute myeloid leukaemia1 trial
- Aortic aneurysm1 trial
- Brain aneurysm1 trial
- Colorectal cancer1 trial
- Gastric and oesophageal cancer1 trial
- High blood pressure1 trial
- Lung cancer1 trial
- Melanoma1 trial
- Neuroendocrine tumours1 trial
- and 3 more
- Phase
- Phase 25 trials
- Phase 34 trials
- Phase 2/31 trial
- Status
- Recruiting6 trials
- Completed5 trials
- Active, not recruiting2 trials
- Terminated2 trials
- Lead sponsor
- Janssen Research & Development, LLC2 trials
- Seagen Inc.2 trials
- Barbara Ann Karmanos Cancer Institute1 trial
- Boehringer Ingelheim1 trial
- Cerenovus, Part of DePuy Synthes Products, Inc.1 trial
- and 8 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute myeloid leukaemia1 recruiting
- Childhood cancers1 recruiting
- Colorectal cancer1 recruiting
- High blood pressure1 recruiting
- Melanoma1 recruiting
- Neuroendocrine tumours1 recruiting
- Pulmonary arterial hypertension1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Completed
Completed
Terminated
Terminated
Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma
Completed
Completed
Ibrutinib in Treating Patients With Relapsed or Refractory Classical Hodgkin Lymphoma
Completed
Site data: ClinicalTrials.govUpdated 13 Nov 2026